EN
HI
RPG Life Sciences Share price
RPGLIFE
2702.7
38.60 (-1.41%)NSE
BSE
Last updated on 18 Aug, 2026 | 15:58 IST
RPG Life Sciences share price chart
RPG Life Sciences Share Key Metrics
Volume
11456.00
Market Cap
4470.00 CR
LTQ@LTP
5@2702.70
ATP
2723.57
Var Margin
20.33 %
Circuit Range
2193.1-3289.5
Delivery %
42.03 %
Value
3.12 CR
ASM/GSM
No
Market Lot
1
Summary
RPGLIFE stock price is ₹2702.7 as of 19 Aug, 2026. The stock intraday movement has stayed between ₹2663.00 and ₹2770.00, while RPG Life Sciences share price 52 week high low is ₹1733.00 & ₹3082.00.
In terms of trading activity, RPGLIFE share price has recorded a volume of 11,456 shares. The RPG Life Sciences has a market cap of ₹16539015. The stock’s Average Traded Price (ATP) stands at ₹2723.57, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5 @ ₹2702.70.
The RPG Life Sciences upper circuit limit is ₹3289.50 & The RPG Life Sciences lower circuit limit is ₹2193.10, with a Value of ₹3.12 CR. The Delivery Percentage for the day is 42.03%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
RPG Life Sciences Resistance and Support
Pivot 2761.4
Resistance
First Resistance
2802.8
Second Resistance
2864.3
Third Resistance
2905.7
Support
First Support
2699.9
Second Support
2658.5
Third Support
2597
RPG Life Sciences Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
72.95%
Mutual Fund
0.04%
Insurance
0.21%
Foreign Institutional Investors
0.95%
Domestic Institutional Investors
6.4%
Retail
19.44%
Others
0.01%
Total Promoters
MAR '26
72.95%
JUN '26
72.95%
RPG Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-27 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-04-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-09 | 2026-07-09 | View More |
RPG Life Sciences News
RPG Life Sciences Ltd - 532983 - Update On API Business Transfer Agreement
RPG Life Sciences completed the internal transfer of its Active Pharmaceuticals Ingredients (API) Business to RPG Active Pharma Limited, a wholly-owned subsidiary, via a slump sale. This restructuring, effective August 15, 2026, aims to streamline operations within the group.
Aug 15 2026 01:03:09
RPG Life Sciences Ltd - 532983 - RPG Life Sciences Limited Has Informed The Exchange About Further Investment In RPG Active Pharma Limited
RPG Life Sciences invested Rs. 65.68 crore in its wholly-owned subsidiary, RPG Active Pharma Limited, by subscribing to a rights issue of equity shares. This investment is for the subsidiary to commence its operations.
Aug 15 2026 00:57:37
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
RPG Life Sciences is set to host an analyst/institutional investors group meet on August 13, 2026, from 9:00 AM onwards. The physical meeting will take place in Mumbai at Emkay Confluence 2026.
Aug 10 2026 14:14:29
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Acquisition
RPG Life Sciences' wholly-owned subsidiary, RPG Active Pharma Limited, acquired a 100% stake in Actis Generics Private Limited for Rs. 80 crore. This acquisition aligns with the company's strategy to expand its Active Pharmaceutical Ingredients (API) business.
Jul 29 2026 23:45:02
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Restructuring
RPG Life Sciences Board approved a multi-faceted restructuring of its API business. The API division will be sold to its WOS, RPG Active Pharma Ltd. (RPGAP). RPGAP will raise Rs.243.33 crore from India Life Sciences Fund IV and Vistaject Fund, and acquire Actis Generics for Rs.80 crore.
Jul 29 2026 23:40:53
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
RPG Life Sciences issued a press release detailing its Q1 FY27 financial results. The company reported a 15.8% increase in revenue to ₹195.7 crore and a 17.9% growth in EBITDA to ₹48.0 crore, with an EBITDA margin of 24.5% driven by operating discipline and market outperformance.
Jul 28 2026 20:11:24
RPG Life Sciences Ltd - 532983 - Board Meeting Outcome for Outcome Of Board Meeting
RPG Life Sciences' board approved Q1 FY27 consolidated financial results on July 28, 2026. Revenue from operations increased 15.85% YoY to ₹195.69 crores, while net profit grew 17.00% YoY to ₹30.76 crores, reflecting strong operational performance.
Jul 28 2026 19:53:42
RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for Financial Result For Quarter Ended June 2026
RPG Life Sciences has scheduled a board meeting for July 28, 2026. The board will consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Jul 21 2026 19:06:29
Read More
RPG Life Sciences Management
| Name | Position |
|---|---|
| Harsh Goenka | Chairman |
| Ashok Nair | Managing Director |
RPG Life Sciences Similar Stocks
Bliss GVS Pharma Ltd.
546.50
26.00 (5.00%)
Supriya Lifescience Ltd.
801.65
17.65 (2.25%)
Artemis Medicare Services Ltd.
312.15
-2.25 (0.72%)
IOL Chemicals And Pharmaceuticals Ltd.
159.19
-2.09 (1.30%)
Morepen Laboratories Ltd.
88.44
-1.38 (1.54%)
Gufic Biosciences Ltd.
421.40
3.20 (0.77%)
Aarti Drugs Ltd.
412.80
2.05 (0.50%)
Gujarat Themis Biosyn Ltd.
371.30
20.05 (5.71%)
Unichem Laboratories Ltd.
529.60
-13.70 (2.52%)
RPG Life Sciences FAQs
The Buying Price of RPG Life Sciences share is 2702.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy RPG Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for RPG Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of RPG Life Sciences shares is 39.27. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio RPG Life Sciences shares is 7.11. Useful to assess the stock's value relative to its book value.
To assess RPG Life Sciences’s valuation compare Sector P/E, P/B which are 63.29 & 3.31 with sector averages, along with growth rates and financial metrics.
The Market Cap of RPG Life Sciences is 4470.00 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of RPG Life Sciences share price is 3082.00 & 1733.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
RPG Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in RPGLIFE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC